Biomaterial-microvasculature interactions

Biomaterials

Volumn 21, Issue 22, 2000, Pages 2233-2241

  Sieminski, Alisha L ^a   Gooch, Keith J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell adhesion; Endothelial cells; Microarchitecture; Microvasculature; Tissue engineering; Transport

Indexed keywords

ADHESION; CELLS; MASS TRANSFER; TISSUE;

ENDOTHELIAL CELLS; MICROVASCULATURE; TISSUE ENGINEERING;

IMPLANTS (SURGICAL);

BIOMATERIAL;

BIOCOMPATIBILITY; BIOENGINEERING; BIOPROSTHESIS; CELL ADHESION; HUMAN; HUMAN TISSUE; MICROVASCULATURE; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; VASCULAR ENDOTHELIUM; ANIMAL; CHEMISTRY; CYTOLOGY; MICROCIRCULATION; PHYSIOLOGY; PROSTHESES AND ORTHOSES; PROSTHESIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN;

EID: 0034670180     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00149-6     Document Type: Article

References (72)

1. Padera R.F., Colton C.K. Time course of membrane microarchitecture-driven neovascularization. Biomaterials. 17:1996;277-284.
2. Black A.F.et al. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 12:1998;1331-1340.
3. Cima L.G.et al. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng. 113:1991;143-151.
4. Mikos A.G.et al. Prevascularization of porous biodegradable polymers. Biotechnol Bioeng. 42:1993;716-723.
5. Mooney D.J.et al. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. Biomed Mater Res. 37(3):1997;413-420.
6. Black A.F.et al. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 12:1998;1331-1340.
7. Cuono C.B. Composite autologous-allogenic skin replacement. development and clinical application Plast Reconstr Surg. 80:1987;626-635.
8. Messina L.M.et al. Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc Natl Acad Sci. 89(24):1992;12018-12022.
9. Gooch K.J.et al. Tissue-engineered microvascular networks for gene therapy. Ann Biomed Eng. 26:1998;S141.
10. Holder W.D.et al. Increased vascularization and heterogeneity of vascular structures occurring in polyglycolide matrices containing aortic endothelial cells implanted in the rat. Tissue Engineering. 3(2):1997;149-160.
11. Beger C.et al. Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation. Diabetes. 47:1998;559-565.
12. Griffith L.G.et al. In vitro organogenesis of liver tissue. Ann NY Acad Sci. 831:1997;382-397.
13. Squinto S.P.et al. The ENCEL system. a somatic cell protein delivery system In Vivo. 8:1994;771-780.
14. Wei Y.et al. Directed endothelial differentiation of cultured embryonic yolk sac cells in vivo provides a novel cell-based system for gene therapy. Stem Cells. 13:1995;541-547.
15. Joseph J.M.et al. Transplantation of encapsulated bovine chromaffin cells in sheep subarachnoid space. a preclinical study for the treatment of cancer pain Cell Transplant. 3:1994;355-364.
16. Tresco P.A.et al. Polymer-encapsulated PC12 cells. long-term survival and associated reduction in lesion-induced rotational behavior Cell Transplant. 1:1992;255-264.
17. Hoffman D.et al. Transplantation of polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol. 122:1993;100-106.
18. al-Hendy A.et al. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - an alternate approach to somatic gene therapy. Hum Gene Ther. 6(2):1995;65-75.
19. Chick W.L.et al. Artificial pancreas using living. β cells - effects on glucose homeostasis in diabetic rats Science. 197:1977;780-782.
20. Gough DA, Armour JC, Development of the implantable glucose sensor. What are the prospects and why is it taking so long? Diabetes 1995;44(9):1005-9.
21. Sharkawy A.A.et al. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res. 37:1997;401-412.
22. Brauker J.H.et al. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res. 29:1995;1517-1524.
23. Menger M.D.et al. Quantitative analysis of neovascularization of different PTFE-implants. Eur J Cardio-thorac Surg. 4:1990;191-196.
24. Salzmann D.L.et al. The effects of porosity on endothelialization of ePTFE implanted in subcutaneous and adipose tissue. J Biomed Mater Res. 34:1997;463-476.
25. Williams S.K.et al. Differential healing and neovascularization of ePTFE implants in subcutaneous versus adipose tissue. J Biomed Mater Res. 35:1997;473-481.
26. Clowes A.W.et al. Mechanisms of arterial graft healing. rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses Am J Pathol. 123:1986;220-230.
27. Clowes A.W.et al. Early endothelial coverage of synthetic arterial grafts. porosity revisited Am J Surg. 153:1987;501-504.
28. Sharkawy A.A.et al. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res. 40:1998;586-597.
29. Sharkawy A.A.et al. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res. 40:1998;598-605.
30. Rosengren A.et al. Reactive capsule formation around soft-tissue implants is related to cell necrosis. J Biomed Mater Res. 46:1999;458-464.
31. Saltzman W.M.et al. Cell interactions with polymers. Lanza R.P.et al. Principles of tissue engineering. 1997;228-246 RG Landes Company, Austin, TX.
32. Cannizzaro S.M.et al. A novel biotinylated degradable polymer for cell-interactive applications. Biotechnol Bioeng. 58:1998;529-535.
33. Cook A.D.et al. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J Biomed Mater Res. 35:1997;513-523.
34. Hubbell J.A.et al. Surface-grafted cell-binding peptides in tissue engineering of the vascular graft. Ann NY Acad Sci. 665:1992;253-258.
35. Aoki T.et al. Endothelial cell differentiation into capillary structures by copolymer surfaces with phenylboronic acid groups. J Biomater Sci Polym Edn. 7(7):1995;539-550.
36. McAuslan B.R., Johnson G. Cell responses to biomaterials I. adhesion and growth of vascular endothelial cells on poly(hydroxyethl methacrylate) following surface modification by hydrolytic etching J Biomed Mater Res. 21:1987;921-935.
37. Blunk T.et al. Colloidal carriers for intravenous drug targeting. plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis Electrophoresis. 14(12):1993;1382-1387.
38. Boudreau N.J., Jones P.L. Extracellular matrix and integrin signaling. the shape of things to come Biochem J. 339:1999;481-488.
39. Folkman J., Moscona A. Role of cell shape in growth control. Nature. 273:1978;345-349.
40. Ingber D.E.et al. Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol. 23(5):1987;387-394.
41. Chen C.S.et al. Geometric control of cell life and death. Science. 276:1997;1425-1428.
42. Hubbell J.A.et al. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Bio/Technology. 9:1991;568-572.
43. Dvorak H.F.et al. Fibrin containing gels induce angiogenesis. implications for tumor stroma generation and wound healing Lab Invest. 57(6):1987;673-686.
44. Haralabopoulos G.C.et al. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Am J Physiol. 273:1997;C239-C245.
45. Dvorak H.F.et al. Fibrin containing gels induce angiogenesis. implications for tumor stroma generation and wound healing Lab Invest. 57(6):1987;673-686.
46. Hoying J.B.et al. Angiogenic potential of microvessel fragments established in three-dimensional collagen gels. In Vitro Cell Dev Biol. 32:1996;409-419.
47. Nicosia R.F.et al. Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol. 154:1993;654-661.
48. Nicosia R.F., Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement gel in three-dimensional cultures of rat aorta. a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot In Vitro Cell Dev Biol. 26:1990;119-128.
49. Shakado S.et al. Effects of extracellular matrices on tube formation on cultured rat hepatic sinusoidal endothelial cells. Hepatology. 22:1995;969-973.
50. Kubota Y.et al. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 107:1988;1589-1598.
51. Ingber D.E., Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro. role of extracellular matrix J Cell Biol. 109:1989;317-330.
52. Takei A.et al. Effects of fibrin on the angiogenesis in vitro of bovine endothelial cells in collagen gel. In Vitro Cell Dev Biol. 31:1995;467-472.
53. Madri J.A., Williams S.K. Capillary endothelial cell cultures. phenotypic modulation by matrix components J Cell Biol. 97:1983;153-165.
54. Vernon R.B.et al. Organized type I collagen influences endothelial patterns during spontaneous angiogenesis in vitro. planar cultures as models of vascular development In Vitro Cell Dev Biol. 31:1995;120-131.
55. Maciag T.et al. Organizational behavior of human umbilical vein endothelial cells. J Cell Biol. 94:1982;511-520.
56. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature. 288:1980;551-556.
57. Chalupowicz D.G.et al. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol. 130:1995;207-215.
58. Montesano R.et al. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol. 97:1983;1648-1652.
59. Kanzawa S.et al. Improved in vitro angiogenesis model by collagen density reduction and the use of type III collagen. Ann Plast Surg. 30:1993;244-251.
60. Matsuda T., Kurumatani H. Surface induced in vitro angiogenesis. surface property is a determinant of angiogenesis ASAIO Trans. 36:1990;M565-M568.
61. Dike L.E.et al. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell Dev Biol. 35:1999;441-448.
62. v integrins. Science. 270:1995;1500-1502.
63. Powers M.J., Griffith L.G. Adhesion-guided in vitro morphogenesis in pure and mixed cell cultures. Microscopy Res Tech. 43:1998;379-384.
64. Ingber D.E., Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro. role of extracellular matrix J Cell Biol. 109:1989;317-330.
65. Matsuda T., Sugawara T. Control of cell adhesion, migration, and orientation on photochemically microprocessed surfaces. J Biomed Mater Res. 32:1996;165-173.
66. Patel N.et al. Spatially controlled cell engineering on biodegradable polymer surfaces. FASEB J. 12:1998;1447-1454.
67. Rosen EM, Goldberg ID, editors. Regulation of angiogenesis. EXS, vol. 79, 1997.
68. Battegay E.J. Angiogenesis. mechanistic insights, neovascular disease, and therapeutic prospects J Mol Med. 73:1995;333-346.
69. Thompson J.A.et al. Site-directed neovessel formation in vivo. Science. 241:1988;1349-1352.
70. Thompson J.A.et al. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. PNAS. 86:1989;7928-7932.
71. Masuda S.et al. Vascular endothelial growth factor enhances vascularization in microporous small caliber polyurethane grafts. ASAIO J. 43:1997;M530-M534.
72. Hunter S.K.et al. Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances. ASAIO J. 45:1999;37-40.